Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 8—August 2003

Research

Multidrug-Resistant Tuberculosis in HIV-Negative Patients, Buenos Aires, Argentina

Domingo Palmero*Comments to Author , Viviana Ritacco†, Martha Ambroggi‡, Marcela Natiello‡, Lucía Barrera†, Lilian Capone‡, Alicia Dambrosi‡, Martha Di Lonardo‡, Nélida Isola‡, Susana Poggi‡, Marisa Vescovo‡, and Eduardo Abbate‡
Author affiliations: *Hospital F. J. Muñiz, Buenos Aires, Argentina; †National Institute of Infectious Diseases “Carlos G. Malbran,” Buenos Aires, Argentina; ‡University of Buenos Aires, Buenos Aires, Argentina

Main Article

Table 1

Demographic, clinical, and bacteriologic features of acquired versus initial multidrug-resistant tuberculosis (MDRTB) cases among 291 HIV-negative patients, Muñiz Hospital, Argentina, 1991–2000

Acquired MDRTB
(n=212) Initial MDRTB
(n=79) p value
Age (y ± SD)
39.8±13.2
35.3±15.0
0.013
Gender (male/female)
125/87
32/47
0.005
Origin (Argentinean/foreign-born)a
180/32
64/15
0.533
Chest x-ray (minimal/moderate/advanced)
2/52/158
10/38/31
<0.0001
Underlying illness (Y/N)
46/166
15/64
0.731
Diabetes (N)
26
7

Alcoholism (N)
9
1

Silicosis (N)
2
1

Steroid treatment (N)
2
3

Substance abuse (N)
1
0

Malignancy (N)
1
2

Other (N)
5
1

Drug resistance, median number of drugs (range) 4 (2–8) 4 (2–6)

aNeighboring countries (Peru, Bolivia, Paraguay).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO